Procter & Gamble Q3 earnings top estimates; raises FY22 top-line guidance
Procter & Gamble Q3 earnings top estimates; raises FY22 top-line guidance
Adjusted EPS of $1.33 beat the consensus of $1.30.$Procter & Gamble(PG.US)$ reported third-quarter FY22 sales growth of 7.1% year-on-year to $19.38 billion, beating the consensus of $18.73 billion.
Organic sales increased 10%, driven by a 3% increase in shipment volume, 5% from improved pricing, and a 2% increase from geographic and product mix.
Sales in the beauty segment rose 2%, the Grooming segment expanded 3%, and Health Care jumped 13%.
Adjusted EPS of $1.33 beat the consensus of $1.30.
Gross profit decreased 1% Y/Y to $9.1 billion. Gross margin decreased by 400 basis points to 46.7%.
Operating margin contracted 10 basis points to 20.8%, while operating income for the quarter rose 6% to $4.02 billion.
P&G held $8.5 billion in cash and equivalents as of March 31, 2022.
Outlook: P&G raised FY22 all-in sales growth outlook to 4% - 5% (previously 3% - 4%).
The company continues to expect FY22 core EPS growth of 3% - 6% versus FY21 Core EPS of $5.66.
P&G also expects to pay over $8 billion in dividends and repurchase $10 billion of common shares in FY22.
$宝洁 (PG.US) $报告称，22财年第三季度的销售额同比增长7.1％，达到193.8亿美元，超过了市场预期的187.3亿美元。
有机销售额增长了10％，这得益于出货量增长了3％，价格提高了5％，地域和产品组合增长了2％。
美容板块的销售额增长了2％，美容板块增长了3％，医疗保健板块增长了13％。
调整后的每股收益为1.33美元，超过了市场普遍的1.30美元。
毛利同比下降1％，至91亿美元。毛利率下降了400个基点至46.7％。
营业利润率收缩了10个基点至20.8％，而该季度的营业收入增长了6％，至40.2亿美元。
截至2022年3月31日，宝洁持有85亿美元的现金及等价物。
展望：宝洁将22财年的总销售增长前景上调至4％至5％（此前为3％-4％）。
该公司继续预计，22财年的核心每股收益将增长3％至6％，而21财年的核心每股收益为5.66美元。
宝洁还预计将在22财年支付超过80亿美元的股息并回购100亿美元的普通股。
